Cetera Investment Advisers
IRMD icon

Cetera Investment Advisers’s iRadimed IRMD Stock Holding History

Cetera Investment Advisers’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Buy
5,641
+402
+8% +$36.6K ﹤0.01% 3631
2026
Q1 		$504K Sell
5,239
-212
-4% -$21.2K ﹤0.01% 3509
2025
Q4 		$530K Buy
5,451
+51
+0.9% +$4.38K ﹤0.01% 3381
2025
Q3 		$384K Buy
+5,400
New +$360K ﹤0.01% 3606

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cetera Investment Advisers's IRMD Position: Q2 2026 in Review

Cetera Investment Advisers increased its iRadimed (IRMD) stake by 7.7% in Q2 2026, buying an estimated $36.6K and bringing the position to 5,641 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #3631.

Cetera Investment Advisers first reported a position in IRMD in Q3 2025 and has held it in 4 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Cetera Investment Advisers held 5,641 shares of iRadimed worth $539K as of Q2 2026.
  • Cetera Investment Advisers bought 402 iRadimed shares in Q2 2026, an estimated $36.6K.
  • iRadimed made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3631 holding.
  • Cetera Investment Advisers first reported a position in iRadimed in Q3 2025 and has held it in 4 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.